Skip to main content
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
94.00
+1.52 (1.64%)
At close: Apr 28, 2026, 4:00 PM EDT
94.02
+0.02 (0.02%)
Pre-market: Apr 29, 2026, 4:24 AM EDT

Mirum Pharmaceuticals Revenue

In the year 2025, Mirum Pharmaceuticals had annual revenue of $521.31M with 54.74% growth. Mirum Pharmaceuticals had revenue of $148.93M in the quarter ending December 31, 2025, with 49.81% growth.

Revenue (ttm)
$521.31M
Revenue Growth
+54.74%
P/S Ratio
11.00
Revenue / Employee
$1,401,376
Employees
372
Market Cap
5.73B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025521.31M184.42M54.74%
Dec 31, 2024336.89M150.51M80.76%
Dec 31, 2023186.37M109.31M141.85%
Dec 31, 202277.06M57.92M302.66%
Dec 31, 202119.14M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PTC Therapeutics 1.73B
Apellis Pharmaceuticals 1.00B
Caris Life Sciences 812.03M
TG Therapeutics 616.29M
Rhythm Pharmaceuticals 189.76M
CG Oncology 4.04M
Revenue Rankings

MIRM News

More News